The NCI Outstanding Investigator Award
The National Cancer Institute (NCI) announces the Outstanding Investigator Award (R35)
NCI’s new Outstanding Investigator Award (OIA) encourages research with breakthrough potential. The OIA will support investigators with outstanding records of productivity in cancer research with up to $600,000 in direct costs per year for 7 years to provide funding stability. NCI anticipates making about 50 awards annually.
The OIA will allow funded investigators the freedom to embark on long-term projects of unusual potential in cancer research; the opportunity to take greater risks and be more adventurous in their lines of inquiry; and sufficient time to develop new techniques.
Applications must be submitted by Institutions who have nominated a Program Director/Principal Investigator (PD/PI) with outstanding productivity in cancer research as a recipient of NCI grant(s) for at least the past 5 years. The PD/PI will be expected to commit at least 50% of his/her research activities to the OIA; the Institution will be expected to commit at least 20% salary support.
Letter of Intent due date: September 20, 2014
Application due date: October 20, 2014, by 5:00 PM local time of applicant organization